Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-25-000022
Filing Date
2025-05-22
Accepted
2025-05-22 17:01:52
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747947705.html 4  
1 FORM 4 wk-form4_1747947705.xml 4 4072
  Complete submission text file 0000886744-25-000022.txt   5614
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
O'Farrell Elizabeth G. (Reporting) CIK: 0001744662 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 25978074